Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.58 USD | +1.98% | +3.20% | -20.37% |
Mar. 21 | Earnings Flash (ARMP) ARMATA PHARMACEUTICALS Reports Q4 Revenue $1.5M | MT |
Mar. 21 | Armata Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.37% | 91.46M | |
+3.97% | 43.43B | |
+47.81% | 41.69B | |
+9.02% | 41.31B | |
-10.92% | 27.14B | |
+9.09% | 25.28B | |
-24.62% | 18.47B | |
+29.41% | 12.59B | |
+1.34% | 12.33B | |
+9.27% | 11.03B |
- Stock Market
- Equities
- ARMP Stock
- News Armata Pharmaceuticals, Inc.
- Armata Pharmaceuticals Says FDA Clears Application for Initial-stage Trial of Investigational Prosthetic Joint Infection Treatment